Ilan Stein
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- NF-κB Signaling Pathways
- Cancer, Hypoxia, and Metabolism
- Immunology top 2%
- Immune cells in cancer
Papers in
-
- Cancer, Hypoxia, and Metabolism 5
- Oncology 10
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Eli Pikarsky (20 shared papers)Yinon Ben‐Neriah (5 shared papers)Rinat Abramovitch (3 shared papers)Rinnat M. Porat (2 shared papers)Eithan Galun (1 shared paper)Simcha Urieli-Shoval (1 shared paper)Sharon Amit (1 shared paper)Eli Keshet (4 shared papers)
- Journals
- Molecular and Cellular Biology (4 papers)Cancer Research (3 papers)Hepatology (3 papers)PLoS ONE (3 papers)Cell Reports (2 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ilan Stein
36 papers receiving 5.5k citations
Ilan Stein's Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 1.8k
- Immunology 1.2k
- Oncology 1.3k
- Hepatology 368
- Molecular Biology 2.7k
Countries citing papers authored by Ilan Stein
This map shows the geographic impact of Ilan Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Stein more than expected).
Fields of papers citing papers by Ilan Stein
This network shows the impact of papers produced by Ilan Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Stein. The network helps show where Ilan Stein may publish in the future.
Co-authors
The 25 scholars most cited alongside Ilan Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NF-κB functions as a tumour promoter in inflammation-associated cancer Hit paper breakdown → | 2004 | 2175 |
| 2 | 1998 | 434 | |
| 3 | 1995 | 403 | |
| 4 | 2015 | 349 | |
| 5 | 2019 | 293 | |
| 6 | 2016 | 264 | |
| 7 | 2014 | 165 | |
| 8 | 2019 | 149 | |
| 9 | 2009 | 135 | |
| 10 | 2009 | 125 | |
| 11 | 1994 | 102 | |
| 12 | 2004 | 98 | |
| 13 | 2014 | 97 | |
| 14 | 2014 | 86 | |
| 15 | 2013 | 85 | |
| 16 | 2010 | 85 | |
| 17 | 1998 | 79 | |
| 18 | 2022 | 77 | |
| 19 | 2018 | 69 | |
| 20 | 2015 | 55 |
About Ilan Stein
Ilan Stein is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Genetics, having authored 36 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Immune cells in cancer (3 papers), RNA modifications and cancer (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), RNA Research and Splicing (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (1.8k citations), Immunology (1.2k citations), Oncology (1.3k citations), Hepatology (368 citations) and Molecular Biology (2.7k citations). Ilan Stein has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Eli Pikarsky, Yinon Ben‐Neriah, Rinat Abramovitch, Rinnat M. Porat, Eithan Galun, Simcha Urieli-Shoval, Sharon Amit, Eli Keshet, Ahuva Itin and Michal Neeman. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research, Hepatology, PLoS ONE and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.